Beyondspring (BYSI) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
BeyondSpring Inc., a biopharmaceutical company, has successfully filed a registration statement with the SEC for the issuance of over 1.2 million ordinary shares, as detailed in a prospectus supplement dated June 12, 2024. This move, executed in accordance with a Securities Purchase Agreement, aims to strengthen the company’s financial position. Legal opinions confirm that the shares, once issued and paid for, will be fully legitimate and non-assessable under Cayman Islands law.
For further insights into BYSI stock, check out TipRanks’ Stock Analysis page.
